Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

An experimental gene therapy that involves injecting CRISPR therapy directly into visually impaired patients’ eyeballs has vastly improved most volunteers’ vision — even allowing some to see color ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This marks the first story ...

An investigational gene therapy has shown promise for improving functional vision and restoring light detection in long-dormant rods and cones in the retina in adults and children with a rare form of ...

The most common types of color blindness, or color vision deficiency, are genetic. However, other types may develop due to injuries, eye diseases, health problems, and side effects of treatment.

Gene therapy scientists have long dreamed of curing blindness. The first commercial gene therapy in the US, Luxturna, was approved by the US Food and Drug Administration in 2017 to partially restore ...

Color is more than a sensory pleasure; it is a tool refined by evolution. Our ability to perceive a broad spectrum of hues is a remarkable biological achievement shaped by survival pressures, social ...